Page 63 - Magyar Gasztroenterológiai Társaság 2020. november 6–7. – ONLINE KONGRESSZUS
P. 63

Előadáskivonatok / Abstracts


             7. Division of Haematology, First Department of Medicine,   Methods:  The  Hungarian  Pancreatic  Study  group  has
             University of Pécs Medical School                prospectively collected multicenter clinical data of 1435 adult
                                                              patients between 2012 and 2017. 1429 of them contained
             Introduction: The goal of treatment in ulcerative colitis (UC)   valuable  data  on  pancreatic  necrosis  and  were  enrolled.
             is  to  induce  and  maintain  remission.  The  addition  of   Statistical  analyses  compared  pancreatitis  with  (ANP)  and
             granulocyte and monocyte apheresis (GMA) to conventional   without necrosis (AP). Predictive models were built by the
             therapy may be a promising therapeutic alternative.    Random Forest approach.
             Aims: In this meta-analysis, we aimed to assess the efficacy   Results:  9.31%  (n=133)  of  the  patients  had  ANP.  As
             and safety profile of GMA.                       expected ANP was associated with higher mortality (8.27%
             Methods: We searched four databases for randomized or   vs 1.93%; p<0.0001), more severe disease (mild: 0.00% vs
             minimized  controlled  trials  which  discussed  the  impact  of   75.69%, moderate: 73.68% vs 20.91%, severe: 26.32% vs
             additional GMA therapy on clinical remission induction and   3.40%),  longer  hospitalization  (22.95±19.23  days  vs
             clinical  remission  maintenance  compared  to  conventional   10.18±7.22  days;  p<0.0001),  and  higher  rate  of
             therapy  alone.  Odds  ratios  (OR)  with  95%  confidence   complications  (pseudocyst:  30.83%  vs  6.34%,  p<0.0001;
             intervals  were  calculated.  The  random-effects  model  was   diabetes:  13.53%  vs  3.24%,  p<0.0001;  respiratory  failure:
             used  to  pool  effect  sizes.  Heterogeneity  was  tested  by   20.45% vs 3.27%, p<0.0001); heart failure: 8.33% vs 1.17%,
             calculating Higgins’ I  indicator.               p<0.0001);  renal  failure:  15.19%  vs  1.71%  ,  p<0.0001).
                             2
             Results:  A  total  of  eleven  studies  were  eligible  for  meta-  Several  risk  factors  were  identified  among  on  admission
             analysis.  GMA  was  clearly  demonstrated  to  induce  and   parameters. After combining these parameters, we created a
             maintain clinical remission more effectively than conventional   predictive model with the Random Forest approach that does
             therapy  alone  (598  patients:  OR:  1.93,  CI:  1.28–2.91,   not include false negative cases.
                     2
             p=0.002,  I =0.0%  for  induction;  71  patients:  OR:  8.34,  CI:   Conclusion:  Pancreatic  necrosis  markedly  influences  the
                               2
             2.64–26.32,  p<0.001,  I =0.0%  for  maintenance).  Although   outcome of acute pancreatitis. Without the presence of false
             reporting  was  diverse  across  studies,  the  frequency  of   negative cases, our model is able to rule out development of
             adverse events did not differ between groups.    ANP in this derivation cohort. After the validation of our result,
             Conclusion:  GMA  appears  to  be  more  effective  as  an   we will translate it into a predictive bioinformatics tool to help
             adjunctive treatment in inducing and maintaining remission   physicians in assessing risk of this severe complication.
             in UC patients than conventional therapy.
                                                              79. THE ORGANOSULFUR DIMETHYL TRISULFIDE MAY
             78.  RISK  PREDICTION  MODEL  FOR  DEVELOPING    ACT AS AN ANTIOXIDANT TO REDUCE THE SEVERITY
             PANCREATIC NECROSIS                              OF EXPERIMENTAL ACUTE PANCREATITIS
                                                3
                                                                         1
                                                                                                           1
                                                                                 1
                             3
                                                                                                 1
                                                                                        1
                                        3
             Kiss S. 1,2,3 , Farkas N. , Fehérvári P. , Pecze L. , Földi M. 1,2,3 ,   Kormányos  E. ,  Balla  Z. ,  Fűr  G. ,  Bálint  E. ,  Totonji  A. ,
             Vincze  Á. ,  Gódi  S. ,  Bajor  J. ,  Czimmer  J. ,  Sarlós  P. ,   Bátai Z. , Pozsgai G. , Börzsönyi Á. , Hegyi P. , Pintér E. ,
                                                                                                           2
                                                                                                  3
                                                                              2
                                                          4
                             5
                                     4
                                                                                          2
                     4
                                                                    2
                                                4
             Hágendorn R. , Takács T. , Izbéki F. , Halász A. , Hamvas   Rakonczay Jr Z. , Kiss L.
                                 1
                        6
                                                                                 1
                                          7
                                                                          1
                                                   7
              8
             J. , Varga M. , Crai S. , Mickevicius A. , Patai Á. , Ihász   1.  Department  of  Pathophysiology,  University  of  Szeged,
                       9
                                            11
                              10
                                                     12
                                    13
                                               13
                        3
             M. ,  Varjú  P. ,  Faluhelyi  N. ,  Farkas  O. ,  Miseta  A. ,   Szeged,  Hungary;  2.  Department  of  Pharmacology  and
                                                         14
               12
                                                 1,3
                              15
                                       3
                      15
             Kelemen D. , Papp R. , Hegyi P. , Szentesi A. , Párniczky   Pharmacotherapy,  University  of  Pécs,  Pécs,  Hungary;  3.
               16
             A. , Hegyi P. 1,3,5                              Institute for Translational Medicine, University of Pécs, Pécs,
             1.  First  Department  of  Internal  Medicine,  University  of   Hungary
             Szeged,  Szeged,  Hungary;  2.  Doctoral  School  of  Clinical
             Medicine,  University  of  Szeged,  Szeged,  Hungary;  3.   Introduction:  Acute  pancreatitis  (AP)  is  an  inflammatory
             Institute  for  Translational  Medicine,  University  of  Pécs   disease  which  doesn’t  have  any  adequate  therapy.  Our
             Medical   School,   Pécs,   Hungary;   4.   Division   of   previous studies have shown that administration of dimethyl
             Gastroenterology, First Department of Medicine, University   trisulfide (DMTS), a member of the organic trisulfide family,
             of  Pécs  Medical  School,  Pécs,  Hungary;  5.  Division  of   reduces the severity of AP.
             Translational  Medicine,  First  Department  of  Medicine,   Aims: to investigate the effects of DMTS on AP and to reveal
             University of Pécs Medical School, Pécs, Hungary; 6. First   its mechanism of action.
             Department of Medicine, University of Pécs Medical School,   Methods:  AP  was  induced  in  FVB/n  mice  by  hourly
             Pécs,  Hungary;  7.  Szent  György  University  Teaching   intraperitoneal injections of 10x50µg/kg cerulein. At the same
             Hospital  of  Fejér  County,  Székesfehérvár,  Hungary;  8.   time  DMTS  was  administered  subcutaneously  3-hourly  in
             Péterfy  Hospital,  Budapest,  Hungary;  9.  Dr.  Réthy  Pál   different  doses.  AP  severity  was  evaluated  by  histological
             Hospital, Békéscsaba, Hungary; 10. Pándy Kálmán Hospital   scoring. Primary mouse pancreatic acinar cells were isolated
             of  Békés  County,  Gyula,  Hungary;  11.  Vilnius  University   by collagenase digestion and were used for in vitro assays
             Hospital   Santaros   Clinics,   Vilnius,   Lithuania;   12.   where   DMTS   was   applied   between   0.1-100µg/ml
             Markusovszky  University  Teaching  Hospital,  Szombathely,   concentrations. MTT and propidium iodide were utilized to
             Hungary; 13. Department of Radiology, University of Pécs   determine acinar viability. Reactive oxygen species (ROS)
                                                                             2+
                                                                                             2+
             Medical  School,  Pécs,  Hungary;  14.  Department  of   and intracellular Ca  concentration ([Ca ]i) measurements
             Laboratory  Medicine,  University  of  Pécs  Medical  School,   were determined by microfluorimetry.
             Pécs,  Hungary;  15.  Department  of  Surgery,  University  of   Results:  2x75  and  2x100mg/kg  DMTS  significantly
             Pécs Medical School, Pécs, Hungary; 16. Heim Pál National   ameliorated cerulein-induced AP severity. 3-60 µg/ml DMTS
             Institute of Pediatrics, Budapest, Hungary       concentrations  increased  the acinar  metabolic  activity  and
                                                              <100  µg/ml  DMTS  did  not  affect  cell  viability  or  necrosis
             Introduction: Necrosis is a major local complication in acute   within 1 hour. DMTS alone did not induce ROS production,
             pancreatitis which affects its outcome.          but  it  markedly  reduced  the  ROS  signal  in  cases  of
             Aims: Our aim was to evaluate the clinical characteristics of   menadione and H2O2 administration. DMTS treatment did not
             acute  necrotizing  pancreatitis  (ANP)  and  to  design  a   influence the [Ca ]i compared to the control.
                                                                           2+
             predictive model for that.                       Conclusion:  DMTS  administration  significantly  alleviated
                                                              the severity of experimental AP. DMTS itself did not affect
                                                                                                          61

                                                                Central European Journal of Gastroenterology and Hepatology   61
                                                                            Volume 6, Supplementum 2 / November 2020
   58   59   60   61   62   63   64   65   66   67   68